Skip to main navigation

Top Bar Nav

Contact Us

Social Icons

linkedin twitter

About Nav

About

Pioneering Pathways

Pioneering Pathways

Medicines Nav

Medicines

Science Nav

Science

Our Purpose Nav

Our Purpose

Our Stories

Our Stories

News Nav

News

IR Nav

Investors

Careers Nav

Careers

Home News Press Release Archive

Press Release Archive

News Nav

News
Press Release Archive
Events Archive
Our Stories

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Press Release Archive

Year

Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt

June 29, 2018

Vyxeos™ Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

June 29, 2018

Jazz Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients

June 27, 2018

Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference

June 6, 2018

Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data for Xyrem® (sodium oxybate) in Pediatric Patients with Narcolepsy with Cataplexy

June 3, 2018

Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea

June 3, 2018

New Survey Highlights Lack of Awareness of Neurologic Effects Related to Excessive Sleepiness in Patients with Obstructive Sleep Apnea

May 31, 2018

Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS

May 24, 2018

Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting

May 10, 2018

Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences

May 9, 2018

Pagination

First page
Previous page
…
Page 23
Page 24
Page 25
Page 26
Current page 27
Page 28
Page 29
Page 30
Page 31
…
Next page
Last page

Displaying 261 - 270 of 559

About Nav

About

Pioneering Pathways Nav

Pioneering Pathways

Medicines Nav

Medicines

Science Nav

Science

Our Purpose Nav

Our Purpose

Our Stories Nav

Our Stories

News Nav

News

Careers Nav

Careers

IR Nav

Investors

© 2024 Jazz Pharmaceuticals plc All Rights Reserved.

Legal Nav

Privacy Statement
Terms of Use
Social Media Global Guidelines
Cookie Policy
Sitemap